In the present study, we retrospectively reviewed consecutive cases of CADM-ILD to clarify the differences in the clinical features and prognosis between anti-MDA-5 antibody-positive and -negative cases, and to determine whether we should separate CADM-ILD by the presence or absence of anti-MDA-5 antibody. Here, IFIH1 is linked to interstitial lung disease.